Table of Contents
- Overview
- Symptoms
- Treatment
- Prevention
- Images
The purpose of treatment is to replace the thyroid hormone that is lacking. Levothyroxine (T4) is the most commonly used medication. However a form of T3 is sometimes used together with thyroxine. A combination of T4 and T3 is also available.
Most people feel their best when TSH level is brought into the 1 - 2 mcIU/mL range. People get the lowest dose that effectively relieves their symptoms and brings their blood tests into the normal range.
Life-long therapy is needed. The condition will come back if therapy is interrupted. You must keep taking your medication even when your symptoms go away.
After you start taking replacement therapy, tell you doctor about any symptoms of increased thyroid activity (hyperthyroidism), such as:
- Heat intolerance
- Rapid weight loss
Restlessness - Sweating
Myxedema coma is treated with
Support Groups
Expectations (prognosis)
With early treatment, the condition can be completely controlled. However, the condition will return if you do not continue to take your medication.
Myxedema coma can result in death.
Complications
Myxedema coma, the most severe form of hypothyroidism, is rare. It may be caused by:
- Certain medications
- Exposure to cold
- Illness
- Infection
Symptoms and signs of myxedema
- Below-normal temperature
- Decreased breathing
- Low blood pressure
Low blood sugar - Unresponsiveness
Other complications include:
- Depression
Heart disease - Increased risk of infection
Infertility Miscarriage Pituitary tumors
Complications that can occur with too much thyroid hormone replacement include:
Atrial fibrillation Osteoporosis - Symptoms of hyperthyroidism
Calling your health care provider
Call your health care provider if you have symptoms of hypothyroidism or myxedema.
Also call if you experience these symptoms after beginning thyroid replacement therapy:
- Excessive sweating
- Heat intolerance
- Rapid heart rate
- Rapid weight loss
- Restlessness
- Symptoms of hyperthyroidism
Previous Section
Review Date: 06/17/2008
Reviewed By: Elizabeth H. Holt, MD, PhD, Assistant Professor of Endocrinology
and Metabolism, Yale University. Review provided by VeriMed
Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical
Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org)
